Requirement of phosphatidylinositol-3 kinase for activation of JNK/SAPKs by PDGF

被引:54
作者
LopezIlasaca, M
Li, WQ
Uren, A
Yu, JC
Kazlauskas, A
Gutkind, JS
Heidaran, MA
机构
[1] ORQUEST BIOTECHNOL,MT VIEW,CA 94043
[2] UNIV JENA,FAC MED,MAX PLANCK RES GRP,D-07747 JENA,GERMANY
[3] NATL INST CANC RES,NIH,BETHESDA,MD 20892
[4] COR THERAPEUT,S SAN FRANCISCO,CA 94080
[5] HARVARD UNIV,SCH MED,DIV SIGNAL TRANSDUCT,BOSTON,MA
[6] NIDR,BETHESDA,MD 20892
关键词
D O I
10.1006/bbrc.1997.6289
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The molecular mechanism by which cell surface receptors stimulate the serine/threonine kinase activity of c-Jun N-terminal kinases (JNKs) was investigated using a transient cotransfection experiments in COS-7 cells, Our data demonstrate that JNK activity is potently induced by platelet derived growth factor (PDGF) upon expression of beta PDGFR wild type (beta RWT). However, PDGF failed to mediate JNK activation in cells expressing beta PDGFR mutant lacking the binding site for phosphatidylinositol-3 (PI-3) kinase but not for phospholipase C gamma (PLC gamma) or Syp. Consistent with this result, a PI-3 kinase inhibitor, wortmannin inhibited activation of JNK by PDGF. Furthermore, overexpression of P110 the catalytic domain of PI-3 kinase was sufficient for activation of JNKs which could be efficiently inhibited by dominant negative forms of Pas, Pac but not of RhoA or Cdc42. Taken together all of these findings suggest that activation of JNK by PDGF involves receptor association with PI-3 kinase activity, which in turn acts on a ras- and rac-dependent pathway. (C) 1997 Academic Press.
引用
收藏
页码:273 / 277
页数:5
相关论文
共 50 条
  • [21] Requirement for phosphatidylinositol-3′-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse
    Morita, Y
    Manganaro, TF
    Tao, XJ
    Martimbeau, S
    Donahoe, PK
    Tilly, JL
    ENDOCRINOLOGY, 1999, 140 (02) : 941 - 949
  • [22] Thapsigargin-induced degranulation of mast cells is dependent on transient activation of phosphatidylinositol-3 kinase
    Huber, M
    Hughes, MR
    Krystal, G
    JOURNAL OF IMMUNOLOGY, 2000, 165 (01) : 124 - 133
  • [23] ACTIVATION OF PHOSPHATIDYLINOSITOL-3' KINASE BY SRC-FAMILY KINASE SH3 BINDING TO THE P85 SUBUNIT
    PLEIMAN, CM
    HERTZ, WM
    CAMBIER, JC
    SCIENCE, 1994, 263 (5153) : 1609 - 1612
  • [24] Phosphatidylinositol-3 kinase is involved in ruffled border formation in osteoclasts
    Nakamura, I
    Sasaki, T
    Tanaka, S
    Takahashi, N
    Jimi, E
    Kurokawa, T
    Kita, Y
    Ihara, S
    Suda, T
    Fukui, Y
    JOURNAL OF CELLULAR PHYSIOLOGY, 1997, 172 (02) : 230 - 239
  • [25] JAK3 PROTEIN-TYROSINE KINASE MEDIATES INTERLEUKIN-7-INDUCED ACTIVATION OF PHOSPHATIDYLINOSITOL-3' KINASE
    SHARFE, N
    DADI, HK
    ROIFMAN, CM
    BLOOD, 1995, 86 (06) : 2077 - 2085
  • [26] Regulation of pancreatic duct cell differentiation by phosphatidylinositol-3 kinase
    Watanabe, Hiroaki
    Saito, Hiroshi
    Ueda, Junji
    Evers, B. Mark
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2008, 370 (01) : 33 - 37
  • [27] Phosphatidylinositol-3′-kinase/AKT signaling is essential in synovial sarcoma
    Friedrichs, Nicolaus
    Trautmann, Marcel
    Endl, Elmar
    Sievers, Elisabeth
    Kindler, Dagmar
    Wurst, Peter
    Czerwitzki, Jacqueline
    Steiner, Susanne
    Renner, Marcus
    Penzel, Roland
    Koch, Arend
    Larsson, Olle
    Tanaka, Shinya
    Kawai, Akira
    Schirmacher, Peter
    Mechtersheimer, Gunhild
    Wardelmann, Eva
    Buettner, Reinhard
    Hartmann, Wolfgang
    INTERNATIONAL JOURNAL OF CANCER, 2011, 129 (07) : 1564 - 1575
  • [28] Activation of T lymphocytes via Qa-2: Participation of phosphatidylinositol-3 (PI-3) kinase
    De Fazio, SR
    Comiskey, M
    Warner, CM
    FASEB JOURNAL, 2004, 18 (04) : A39 - A39
  • [29] Inositol hexaphosphate inhibits cell transformation and activator protein 1 activation by targeting phosphatidylinositol-3' kinase
    Huang, CS
    Ma, WY
    Hecht, SS
    Dong, ZG
    CANCER RESEARCH, 1997, 57 (14) : 2873 - 2878
  • [30] PHOSPHATIDYLINOSITOL-3 KINASE AND NF-kB AS POTENTIAL THERAPEUTIC TARGETS IN MYELOID MALIGNANCIES ASSOCIATED WITH HYPEREOSINOPHILIA AND PDGF RECEPTOR REARRANGEMENTS
    Montano-Almendras, C.
    Essaghir, A.
    Schoemans, H.
    Noel, L.
    Velghe, A.
    Varis, I.
    Latinne, D.
    Knoops, L.
    Demoulin, J. B.
    HAEMATOLOGICA, 2012, 97 : 376 - 376